6.27049.64% ( +2.080 )
Closed: Oct 23, 16:00:00 (EDT)Forecast & Rating3 analysts currently cover Bolt Biotherapeutics, of which 2 give a positive rating. The average price target is $41.00, about 553.9% upside from the current price of $6.27. Coverage is limited, so the data is for reference only. Data as of Oct 23, 2026; this does not constitute investment advice.
Oct 23, 2026Price forecast
$41.00553.91%
Forecast & RatingBuy
3analysts
- Strong buy66.67%
- Buy0.00%
- Hold33.33%
- Sell0.00%
- Strong sell0.00%
- Strong buy
- 2
- Buy
- 0
- Hold
- 1
- Sell
- 0
- Strong sell
- 0
Target price forecast
Forecast dateOct 19, 2026
Forecast met0.0%
Stock price$6.27
Avg. target$22.0
High target$75
Low target$1
- Avg. target
- $22.0
- High target
- $75
- Low target
- $1
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.
